Potential clinical application of chimeric antigen receptor T-cell (CAR-T) therapy within the management of diffuse large B-cell lymphoma in 2018. From Chow VA, et al. Translating anti-CD19 CAR-T therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma. Blood. 2018;132:777-781. ASCT, autologous stem cell transplantation.